{COPYRIGHT NASAL DELIVERY A NEW HOPE FOR MENTAL WELLBEING CHALLENGES IN EUROPE ?

The introduction of esketamine delivery system represents a significant change in the treatment of treatment-resistant depression across the EU . While traditionally requiring in-clinic administration, this method allows for a more scope of patient accessibility , although specialist supervision